期刊文献+

酵母葡聚糖硫酸酯化物的结构鉴定和初步药理活性研究 被引量:2

Study on Chemical Properties and Pharmacological Activities of Sulfated β-(1→3)-D-glucan
原文传递
导出
摘要 对酵母β-(1→3)-D-葡聚糖降解后进行硫酸化修饰,研究其硫酸酯化物(PSC)的理化性质,初步了解其结构和药理活性。采用硫酸降解酵母β-(1→3)-D-葡聚糖后,以氯磺酸-吡啶法合成硫酸酯化物,通过紫外、红外及核磁共振等方法进行检测和鉴定;通过体外凝血实验和免疫活性测定实验对其活性进行初步研究。PSC为一相对分子质量为8000左右的多糖,硫酸化修饰后多糖的取代度为2.6。在体外,PSC具有促进脾淋巴细胞增殖的作用,同时PSC能够明显延长部分凝血酶活酶活化时间(APTT)和凝血酶时间(TT)。降解修饰酵母葡聚糖后得到的硫酸酯化产物PSC具有一定免疫增强和抗凝血活性。 In the research, a sulfated derivative ofβ- ( 1 →3 )-D-glucan, named PSC was prepared and studied on the physicochemical properties and pharmacological activities. β- ( 1 →3 )-D-glucan was used as a starting material. It was degraded by sulfuric acid and modified using ehlorosulfonic-pyridine method to obtain PSC. The structure of PSC was identifieated by molecular weight determination, elemental analysis, PMP precolumn derivation, IR and NMR. The basic pharmacological activities of PSC were determined by anti-coagulation test and lymphocyte transformation test. The results showed that PSC is a linear β- ( 1 →3 )-D-glucan of approximately 8 000 u with the sulfate Ds = 2.6. In vitro, PSC showed the ability to facilitate mouse splenocyte proliferation. PSC also showed to be a potent promoter of splenocyte proliferation induced by ConA or LPS mitogens. In the anti-coagulation test, PSC significantly prolonged the activated partial thromboplastin time (APTT) and thrombin time (TT). PSC would have anti-coagulant activity and immunological function.
出处 《药物生物技术》 CAS CSCD 2011年第6期496-500,共5页 Pharmaceutical Biotechnology
关键词 酵母Β-葡聚糖 硫酸酯化 细胞免疫 抗血小板聚集 β- ( 1 →3 ) -D-glucan, Characterization, Immune activity, Anti-coagulant activity
  • 相关文献

参考文献15

二级参考文献105

共引文献146

同被引文献27

  • 1董国强,张孟白,林开江.半纤维素酶的DNS液显色法测定[J].浙江农业科学,1989,30(2):88-89. 被引量:27
  • 2蒋月,张秀英.抗病毒药物作用机理的分子水平研究[J].中国兽医杂志,2006,42(1):55-57. 被引量:3
  • 3Thomas H, Katrin P, Katrin S,et al. Carboxymethyl xylan-control of properties by synthesis [ J ]. Macromol Sympo, 2005, 232 (1) :27.
  • 4Van Dongen FEM, Van Eylen D, Kabel MA. Characterization of substituents in xylans from corn cobs and stover[J]. Carbohydrate Polymers ,2011,86(2) :722.
  • 5Samanta AK, Senani S, Kohe AP, et al. Production and in vitro evaluation of xylooliosaceharides generated from corn cobs [ J ]. Food Bioprod Process, 2012,90 ( 3 ) :466.
  • 6Ebringerova A, Kardosova A, I-Iromadkova Z, et al. Immunomodu- latory activity of acidic xylans in relation to their structural and molecular properties [ J 1. Internat J Bio Macromol, 2002, 30 (1) :1.
  • 7Ebringerovfi A, Hromfidkovfi Z, Hribalova V, et al. Effect of ultra- sound on the immunogenic corn cob xylan [ J 1. Ultrason Sono- chem,1997 ,16( 4 ) :311.
  • 8Oliveira EE, Sliva AE, Junior TN, et al. Xylan from corn cobs, a promising polymer for drug delivery:Production and characteriza. tion[J]. Biores Technol ,2010 ,101(14 ) :5402.
  • 9Silva AKA, Silva EL, Oliveira EE, et al. Synthesis and character- ization of xylan-coated magnetite micropariticles [ J ]. Internat J Pharmac ,2007,334:42.
  • 10Sinha VR, Kumria R. Polysaccharide in colon-specific drug deliv- ery[ J]. Interna J Pharmac ,2001,224 : 19.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部